Audio Described: Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers
2:55
YouTubeNational Cancer Institute
Audio Described: Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers
This phase 2 clinical trial, led by Dr. Marta Penas-Prado, is for adults (age 18 or above) with rare brain and spine tumors. The goal is to test whether stimulating the immune system using the drug nivolumab can shrink these tumors or increase the time it takes for them to grow or spread. Questions? Contact the NCI Neuro-Oncology Branch at (240 ...
4.3K viewsAug 5, 2024
Nivolumab Side Effects
Fast-track Cancer Treatment Starts In England, Nivolumab Injection Revolutionises Cancer Care In UK
1:53
Fast-track Cancer Treatment Starts In England, Nivolumab Injection Revolutionises Cancer Care In UK
YouTubeWION
8.9K views8 months ago
Dr Donington on the Evolving Use of Perioperative Nivolumab in Resectable NSCLC
1:28
Dr Donington on the Evolving Use of Perioperative Nivolumab in Resectable NSCLC
YouTubeOncLive
48 views5 months ago
Nivolumab plus ipilimumab for untreated unresectable or metastatic colorectal cancer
0:44
Nivolumab plus ipilimumab for untreated unresectable or metastatic colorectal cancer
YouTubeNational Institute for Health
173 views7 months ago
Top videos
Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers
2:00
Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers
YouTubeNational Cancer Institute
4.6K viewsAug 5, 2024
Nivolumab in Advanced Hodgkin’s Lymphoma | NEJM
2:28
Nivolumab in Advanced Hodgkin’s Lymphoma | NEJM
YouTubeNEJM Group
2.5K viewsOct 18, 2024
Opdivo (nivolumab): Uses, How It Works, and Common Side Effects
1:44
Opdivo (nivolumab): Uses, How It Works, and Common Side Effects
YouTubeDrugs.com
1.7K views8 months ago
Nivolumab Treatment
Unveiling the Power of Nivolumab: How It Works, Uses, and Potential Side Effects
9:25
Unveiling the Power of Nivolumab: How It Works, Uses, and Potential Side Effects
YouTubeInevid
1.8K viewsSep 13, 2023
Dr He on the FDA Approval of Nivolumab Plus Ipilimumab for Unresectable/Metastatic HCC
1:33
Dr He on the FDA Approval of Nivolumab Plus Ipilimumab for Unresectable/Metastatic HCC
YouTubeOncLive
194 views9 months ago
NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
3:41
NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
YouTubeNEJM Group
261 viewsOct 9, 2024